KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Assets Average (2016 - 2025)

Historic Assets Average for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to $224.6 million.

  • Rigel Pharmaceuticals' Assets Average rose 6774.63% to $224.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.6 million, marking a year-over-year increase of 6774.63%. This contributed to the annual value of $140.6 million for FY2024, which is 1180.78% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Assets Average stood at $224.6 million for Q3 2025, which was up 6774.63% from $191.4 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Assets Average high stood at $224.6 million for Q3 2025, and its period low was $116.2 million during Q3 2023.
  • Moreover, its 5-year median value for Assets Average was $138.5 million (2022), whereas its average is $152.1 million.
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 3723.27% in 2022, then soared by 6774.63% in 2025.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Assets Average stood at $176.9 million in 2021, then decreased by 29.38% to $124.9 million in 2022, then fell by 6.94% to $116.3 million in 2023, then skyrocketed by 30.46% to $151.7 million in 2024, then soared by 48.08% to $224.6 million in 2025.
  • Its last three reported values are $224.6 million in Q3 2025, $191.4 million for Q2 2025, and $170.0 million during Q1 2025.